Gene · 10148
Papers1,901
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,901
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cellular crosstalk of macrophages and therapeutic implications in non-small cell lung cancer revealed by integrative inference of single-cell transcriptomics. | Front Pharmacol | 2023 | 38044943 | PubTator, text mining | PubMed |
| Expression and Prognostic Value of m6A RNA Methylation-Related Genes in Thyroid Cancer. | Iran J Public Health | 2023 | 38033847 | PubTator, text mining | PubMed |
| Cell-based therapies for the treatment of rheumatoid arthritis. | Immun Inflamm Dis | 2023 | 38018576 | PubTator, text mining | PubMed |
| Characterization of target gene regulation by the two Epstein-Barr virus oncogene LMP1 domains essential for B-cell transformation. | mBio | 2023 | 38009935 | PubTator, text mining | PubMed |
| Exploration of biomarkers for systemic lupus erythematosus by machine-learning analysis. | BMC Immunol | 2023 | 37950194 | PubTator, text mining | PubMed |
| Effect of T-regulatory cells and interleukin-35, interleukin-10, and transforming growth factor-beta on diffuse large B-cell lymphoma. | World J Clin Cases | 2023 | 37946782 | PubTator, text mining | PubMed |
| Interleukin-27 tackles immunosuppression in chronic lymphocytic leukemia. | Oncoimmunology | 2023 | 37937211 | PubTator, text mining | PubMed |
| Revisiting regulatory T cells as modulators of innate immune response and inflammatory diseases. | Front Immunol | 2023 | 37928540 | PubTator, text mining | PubMed |
| Engineered small extracellular vesicles as a novel platform to suppress human oncovirus-associated cancers. | Infect Agent Cancer | 2023 | 37915098 | PubTator, text mining | PubMed |
| Interleukin-27-induced HIV-resistant dendritic cells suppress reveres transcription following virus entry in an SPTBN1, autophagy, and YB-1 independent manner. | PLoS One | 2023 | 37910521 | PubTator, text mining | PubMed |
| N6-Methyladenosine (m6A) Modification in Natural Immune Cell-Mediated Inflammatory Diseases. | J Innate Immun | 2023 | 37903470 | PubTator, text mining | PubMed |
| A Disulfidptosis-Related Gene Signature Associated with Prognosis and Immune Cell Infiltration in Osteosarcoma. | Bioengineering (Basel) | 2023 | 37892851 | PubTator, text mining | PubMed |
| Human interleukin-12α and EBI3 are cytokines with anti-inflammatory functions. | Sci Adv | 2023 | 37878703 | PubTator, text mining | PubMed |
| Transcriptomic analysis identifies lactoferrin-induced quiescent circuits in neonatal macrophages. | Front Immunol | 2023 | 37868991 | PubTator, text mining | PubMed |
| Paracrine activin B-NF-κB signaling shapes an inflammatory tumor microenvironment in gastric cancer via fibroblast reprogramming. | J Exp Clin Cancer Res | 2023 | 37858201 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals molecular signature and cell-type difference of Homo sapiens endothelial-to-mesenchymal transition. | G3 (Bethesda) | 2023 | 37857450 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals pro-invasive cancer-associated fibroblasts in hypopharyngeal squamous cell carcinoma. | Cell Commun Signal | 2023 | 37853464 | PubTator, text mining | PubMed |
| Hypoxia stabilizes SETDB1 to maintain genome stability. | Nucleic Acids Res | 2023 | 37850636 | PubTator, text mining | PubMed |
| The yin and yang of B cells in a constant state of battle: intestinal inflammation and inflammatory bowel disease. | Front Immunol | 2023 | 37849749 | PubTator, text mining | PubMed |
| The Role and Mechanism of Retinol and Its Transformation Product, Retinoic Acid, in Modulating Oxidative Stress-Induced Damage to the Duck Intestinal Epithelial Barrier In Vitro. | Animals (Basel) | 2023 | 37835704 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10148/papers?page=6